PL2331682T3 - Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX - Google Patents

Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX

Info

Publication number
PL2331682T3
PL2331682T3 PL09791266T PL09791266T PL2331682T3 PL 2331682 T3 PL2331682 T3 PL 2331682T3 PL 09791266 T PL09791266 T PL 09791266T PL 09791266 T PL09791266 T PL 09791266T PL 2331682 T3 PL2331682 T3 PL 2331682T3
Authority
PL
Poland
Prior art keywords
strains
infectious bronchitis
vaccines derived
bronchitis vaccines
derived
Prior art date
Application number
PL09791266T
Other languages
English (en)
Inventor
Harmen Jacob Geerligs
Cindy Aleida Maria Meinders
Geert Jan Boelm
Bastiana Geertruida Elisabeth Stuurman
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL2331682T3 publication Critical patent/PL2331682T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL09791266T 2008-08-08 2009-08-07 Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX PL2331682T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8722808P 2008-08-08 2008-08-08
EP09791266.1A EP2331682B1 (en) 2008-08-08 2009-08-07 Infectious bronchitis vaccines derived from ib-qx-like strains
PCT/US2009/053085 WO2010017440A1 (en) 2008-08-08 2009-08-07 Infectious bronchitis vaccines derived from ib-qx-like strains

Publications (1)

Publication Number Publication Date
PL2331682T3 true PL2331682T3 (pl) 2019-03-29

Family

ID=41211689

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09791266T PL2331682T3 (pl) 2008-08-08 2009-08-07 Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX

Country Status (26)

Country Link
US (1) US9296991B2 (pl)
EP (1) EP2331682B1 (pl)
JP (3) JP2011530294A (pl)
KR (2) KR101732240B1 (pl)
CN (1) CN102239252B (pl)
AR (1) AR072976A1 (pl)
AU (1) AU2009279528A1 (pl)
BR (1) BRPI0917447A2 (pl)
CA (1) CA2732822C (pl)
CL (1) CL2011000262A1 (pl)
CO (1) CO6351810A2 (pl)
CY (1) CY1121567T1 (pl)
DK (1) DK2331682T3 (pl)
ES (1) ES2702089T3 (pl)
HU (1) HUE041481T2 (pl)
LT (1) LT2331682T (pl)
ME (1) ME01270B (pl)
MX (1) MX339731B (pl)
PL (1) PL2331682T3 (pl)
PT (1) PT2331682T (pl)
RU (1) RU2568053C2 (pl)
SI (1) SI2331682T1 (pl)
TR (1) TR201819340T4 (pl)
UA (1) UA103330C2 (pl)
WO (1) WO2010017440A1 (pl)
ZA (1) ZA201100849B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2895324A1 (en) 2012-12-18 2014-06-26 Merial, Inc. High resolution melt genotyping of ibv, csfv and ndv
CN103028112B (zh) * 2012-12-31 2014-08-06 青岛易邦生物工程有限公司 一种鸡新城疫和传染性支气管炎二联活疫苗
CN103146654B (zh) * 2013-03-25 2014-07-30 浙江诺倍威生物技术有限公司 一株人工弱化的鸡传染性支气管炎病毒及其应用
KR20180129926A (ko) * 2016-06-02 2018-12-05 조에티스 서비시즈 엘엘씨 감염성 기관지염에 대한 백신
CN108950068B (zh) * 2018-07-18 2021-05-07 浙江大学 一种鸡传染性支气管炎病毒qx型毒株鉴别检测试剂盒
JP7206383B2 (ja) * 2018-10-31 2023-01-17 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 異種スパイクタンパク質を有する4/91 ibvワクチン
WO2020229249A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein
WO2024019579A1 (ko) * 2022-07-22 2024-01-25 주식회사 카브 닭전염성기관지염바이러스 약독화주 및 이를 포함하는 백신조성물
CN116375819A (zh) * 2023-01-12 2023-07-04 乾元浩生物股份有限公司 一种鸡传染性支气管炎s蛋白抗体酶联免疫检测试剂盒
KR102717877B1 (ko) * 2023-06-16 2024-10-16 주식회사 지나이너 외래 qx 유사 바이러스 스파이크 단백질을 포함하는 전염성 기관지염 키메라 바이러스 및 이를 포함하는 백신 조성물
CN121941508A (zh) * 2023-09-11 2026-04-28 勃林格殷格翰动物保健(中国)有限公司 减毒的传染性支气管炎病毒和包含其的疫苗
GB2640725A (en) 2024-05-03 2025-11-05 Genera Dionicko Drustvo Vaccine
CN119320459B (zh) * 2024-06-03 2025-04-11 中国动物卫生与流行病学中心 一种鸡传染性支气管炎病毒抗原表位融合肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5037650A (en) * 1988-03-08 1991-08-06 Akzo N.V. Live combination vaccine
EP0639640B1 (en) * 1993-07-30 2000-10-04 Akzo Nobel N.V. Poultry vaccine containing infections bronchitis virus strain 4/91
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ(in ovo)ワクチン
US20010046500A1 (en) 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
PT1610817E (pt) 2003-03-03 2010-01-18 Animal Health Inst Vírus da bronquite infecciosa com um gene da espícula alterado
US7291342B2 (en) 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine

Also Published As

Publication number Publication date
RU2011104201A (ru) 2012-08-20
CA2732822C (en) 2016-09-20
CL2011000262A1 (es) 2011-05-06
UA103330C2 (ru) 2013-10-10
KR101732240B1 (ko) 2017-05-02
CY1121567T1 (el) 2020-05-29
TR201819340T4 (tr) 2019-01-21
US20110305726A1 (en) 2011-12-15
MX2011001514A (es) 2011-03-29
MX339731B (es) 2016-06-08
SI2331682T1 (sl) 2019-01-31
JP2011530294A (ja) 2011-12-22
CN102239252A (zh) 2011-11-09
KR20110038181A (ko) 2011-04-13
ES2702089T3 (es) 2019-02-27
CO6351810A2 (es) 2011-12-20
JP2015144605A (ja) 2015-08-13
WO2010017440A1 (en) 2010-02-11
JP2017212976A (ja) 2017-12-07
ME01270B (me) 2013-06-20
PT2331682T (pt) 2018-12-19
DK2331682T3 (en) 2018-12-10
EP2331682A1 (en) 2011-06-15
JP6397539B2 (ja) 2018-09-26
BRPI0917447A2 (pt) 2015-12-01
RU2568053C2 (ru) 2015-11-10
CN102239252B (zh) 2015-04-15
US9296991B2 (en) 2016-03-29
ZA201100849B (en) 2015-10-28
HUE041481T2 (hu) 2019-05-28
AR072976A1 (es) 2010-10-06
HK1159164A1 (zh) 2012-07-27
CA2732822A1 (en) 2010-02-11
LT2331682T (lt) 2018-12-10
EP2331682B1 (en) 2018-10-24
AU2009279528A1 (en) 2010-02-11
KR20150020623A (ko) 2015-02-26

Similar Documents

Publication Publication Date Title
ZA201100849B (en) Infectious bronchitis vaccines derived from ib-qx-like strains
IL211233A0 (en) Vaccine
IL208660A0 (en) Coccididosis vaccines
IL208651A0 (en) Vaccine
IL214098A0 (en) Hepatitis c virus inhibitors
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
GB0822001D0 (en) Vaccine
IL212311A0 (en) Immunoenhancer-linked oligomeric hiv vaccines
GB0810710D0 (en) Vaccine
ZA201100889B (en) Vaccine against hpv
GB0906234D0 (en) Vaccine
ZA201007402B (en) Vaccine
ZA201100962B (en) Influenza vaccines
GB0816447D0 (en) Vaccine
GB0816284D0 (en) Vaccine
GB0907935D0 (en) Vaccines
GB0801326D0 (en) Vaccines
GB0900455D0 (en) Vaccine
EP2337847A4 (en) ADJUVANTS FOR VACCINES
EP2240199A4 (en) INFLUENZA B VACCINES
GB0818459D0 (en) Vaccines
GB0802108D0 (en) Vaccine
GB0810215D0 (en) Vaccine
GB0809781D0 (en) Vaccine
AU2008267307A1 (en) Vaccine